Tessie 0.3 mg/mL Oral Solution for Dogs, containing TASIPIMIDINE SULFATE

The Australian Pesticides and Veterinary Medicines Authority (APVMA) is considering an application for approval of the new active constituent TASIPIMIDINE SULFATE, and registration of the product Tessie 0.3 mg/mL Oral Solution for Dogs (containing the new active constituent, TASIPIMIDINE SULFATE) for the short-term alleviation of situational anxiety and fear in dogs triggered by noise or owner departure.

Public Release Summary on the evaluation of the new active (Z,E)-7,9,11-dodecatrienyl formate in the product Semios Carob Moth Aerosol Pheromone

The Australian Pesticides and Veterinary Medicines Authority (APVMA) is considering an application for the registration of the product Semios Carob Moth Aerosol Pheromone, containing 12.5 g/L ((Z, E) -7,9,11-dodecatrienyl formate) -7,9,11-dodecatrienyl formate, as an Aerosol formulation (AE). The product is intended for the management of Carob Moth (Ectomyelois ceratoniae) in almond trees through the process of mating disruption in orchards.

Gazette No 3, Tuesday 10 February 2026

Contents

  • Agricultural chemical products and approved labels 1
  • Veterinary chemical products and approved labels 7
  • Approved active constituents 12
  • New veterinary chemical product containing a new veterinary active constituent 14
  • Application for the approval of a new active constituent – Sugar beet extract 29
  • Application for registration of a new product – Actavan® Bio Plant Defence Elicitor containing sugar beet extract 31
  • Application for the a

Public Release Summary on the evaluation of the new active sugar beet extract in the product Actavan® Bio Plant Defence Elicitor

The Australian Pesticides and Veterinary Medicines Authority (APVMA) is considering an application for the registration of the product Actavan® Bio Plant Defence Elicitor, containing 900 g/L of sugar beet extract, as a soluble concentrate (SL) formulation. The product is for use in wine and table grape, to enhance the plant defences, increasing their resistance to botrytis infection.

We invite comment from 10 February to 10 March 2026 on whether registration of the product should be granted.